VELEKA MAYFIELD: Open Payments
NPI 1750001921 · CHESTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,769 in 89 payments from 15 companies in 2025. Trend: 2023 $1,760 · 2024 $2,894 · 2025 $2,769
Food & beverage: $2,769
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $582 |
| AstraZeneca Pharmaceuticals LP | 16 | $572 |
| Novo Nordisk Inc | 21 | $381 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $325 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $309 |
| SANOFI PASTEUR INC. | 4 | $140 |
| Phathom Pharmaceuticals, Inc. | 1 | $114 |
| Amgen Inc. | 5 | $94 |
| PFIZER INC. | 3 | $57 |
| Lilly USA, LLC | 3 | $48 |
Products named: Kerendia, CAPLYTA, VRAYLAR, FARXIGA, BREZTRI, AIRSUPRA, Ozempic, Wegovy.
Industry payments across SC — which companies pay providers there.
